Susan Nmn Ungar

Array ( [id] => 4001319 [patent_doc_number] => 05888507 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-03-30 [patent_title] => 'Treatment for insulin dependent diabetes' [patent_app_type] => 1 [patent_app_number] => 8/447118 [patent_app_country] => US [patent_app_date] => 1995-05-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 8 [patent_no_of_words] => 15441 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 85 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/888/05888507.pdf [firstpage_image] =>[orig_patent_app_number] => 447118 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1560910 [patent_doc_number] => 06361984 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-03-26 [patent_title] => 'MDK1 polypeptides' [patent_app_type] => B1 [patent_app_number] => 08/438265 [patent_app_country] => US [patent_app_date] => 1995-05-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 36820 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 26 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/361/06361984.pdf [firstpage_image] =>[orig_patent_app_number] => 08438265 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4187859 [patent_doc_number] => 06129914 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-10-10 [patent_title] => 'Bispecific antibody effective to treat B-cell lymphoma and cell line' [patent_app_type] => 1 [patent_app_number] => 8/397411 [patent_app_country] => US [patent_app_date] => 1995-03-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 24 [patent_no_of_words] => 16169 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 9 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/129/06129914.pdf [firstpage_image] =>[orig_patent_app_number] => 397411 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3863097 [patent_doc_number] => 05795961 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-08-18 [patent_title] => 'Recombinant human anti-Lewis b antibodies' [patent_app_type] => 1 [patent_app_number] => 8/388672 [patent_app_country] => US [patent_app_date] => 1995-02-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 7996 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 21 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/795/05795961.pdf [firstpage_image] =>[orig_patent_app_number] => 388672 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3846887 [patent_doc_number] => 05719030 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-02-17 [patent_title] => 'Monoclonal antibody to prostate-derived acid phosphatase and method for determination of acid phosphatase using the same as well as kit for determination' [patent_app_type] => 1 [patent_app_number] => 8/380243 [patent_app_country] => US [patent_app_date] => 1995-01-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 4078 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 134 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/719/05719030.pdf [firstpage_image] =>[orig_patent_app_number] => 380243 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4411656 [patent_doc_number] => 06300482 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-10-09 [patent_title] => 'MDKI, a novel receptor tyrosine kinase' [patent_app_type] => 1 [patent_app_number] => 8/368776 [patent_app_country] => US [patent_app_date] => 1995-01-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 37300 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 13 [patent_words_short_claim] => 20 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/300/06300482.pdf [firstpage_image] =>[orig_patent_app_number] => 368776 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4051595 [patent_doc_number] => 05969109 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-10-19 [patent_title] => 'Chimeric antibodies comprising antigen binding sites and B and T cell epitopes' [patent_app_type] => 1 [patent_app_number] => 8/363276 [patent_app_country] => US [patent_app_date] => 1994-12-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 33 [patent_figures_cnt] => 51 [patent_no_of_words] => 23543 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 74 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/969/05969109.pdf [firstpage_image] =>[orig_patent_app_number] => 363276 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3866595 [patent_doc_number] => 05837524 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-11-17 [patent_title] => 'PYK2 related polynucleotide products' [patent_app_type] => 1 [patent_app_number] => 8/357642 [patent_app_country] => US [patent_app_date] => 1994-12-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 28683 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 26 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/837/05837524.pdf [firstpage_image] =>[orig_patent_app_number] => 357642 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3773375 [patent_doc_number] => 05817513 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-10-06 [patent_title] => 'Anti ganglioside monoclonal antibodies' [patent_app_type] => 1 [patent_app_number] => 8/353560 [patent_app_country] => US [patent_app_date] => 1994-12-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 6681 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 94 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/817/05817513.pdf [firstpage_image] =>[orig_patent_app_number] => 353560 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3998303 [patent_doc_number] => 06004554 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-12-21 [patent_title] => 'Methods for targeting the vasculature of solid tumors' [patent_app_type] => 1 [patent_app_number] => 8/295868 [patent_app_country] => US [patent_app_date] => 1994-12-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 25 [patent_no_of_words] => 34985 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 153 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/004/06004554.pdf [firstpage_image] =>[orig_patent_app_number] => 295868 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4411770 [patent_doc_number] => 06265556 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-07-24 [patent_title] => 'Nucleic acid encoding CD40 associated proteins' [patent_app_type] => 1 [patent_app_number] => 8/349357 [patent_app_country] => US [patent_app_date] => 1994-12-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 19571 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 27 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/265/06265556.pdf [firstpage_image] =>[orig_patent_app_number] => 349357 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3872042 [patent_doc_number] => 05824510 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-10-20 [patent_title] => 'Monoclonal antibodies to human influx peptide transporter' [patent_app_type] => 1 [patent_app_number] => 8/347760 [patent_app_country] => US [patent_app_date] => 1994-12-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 9297 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 54 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/824/05824510.pdf [firstpage_image] =>[orig_patent_app_number] => 347760 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4297781 [patent_doc_number] => 06184342 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-02-06 [patent_title] => 'Synthetic peptide neutrophil cell chemotactic agents' [patent_app_type] => 1 [patent_app_number] => 8/330594 [patent_app_country] => US [patent_app_date] => 1994-10-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 10 [patent_no_of_words] => 4733 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/184/06184342.pdf [firstpage_image] =>[orig_patent_app_number] => 330594 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4292846 [patent_doc_number] => 06184013 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-02-06 [patent_title] => 'Catalytic antibodies against cocaine and methods of using and producing same' [patent_app_type] => 1 [patent_app_number] => 8/313291 [patent_app_country] => US [patent_app_date] => 1994-10-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 5 [patent_no_of_words] => 19860 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 33 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/184/06184013.pdf [firstpage_image] =>[orig_patent_app_number] => 313291 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3880086 [patent_doc_number] => 05728821 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-03-17 [patent_title] => 'Mutant BR96 antibodies reactive with human carcinomas' [patent_app_type] => 1 [patent_app_number] => 8/285936 [patent_app_country] => US [patent_app_date] => 1994-08-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 23 [patent_figures_cnt] => 25 [patent_no_of_words] => 25540 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 60 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/728/05728821.pdf [firstpage_image] =>[orig_patent_app_number] => 285936 [rel_patent_id] =>[rel_patent_doc_number] =>)